Quality Of Life In Colorectal Cancer Survivors
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 368
- 试验地点
- 1
- 主要终点
- Quality of Life Score (EORTC QLQ-C30 Global Health Status/QoL Scale)
研究概览
简要总结
The purpose of this study is to identify late adverse effects in colorectal cancer patients that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study aims to assess quality of life in colorectal cancer survivors in relation to psycho-physical-social well-being at different time points and to evaluate the prevalence of late adverse effects and their association with diagnosis and specific oncological treatment.
详细描述
The purpose of this study is to identify late adverse effects in patients with colorectal cancer that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study will assess quality of life in colorectal cancer patients in relation to psycho-physical-social well-being at different time points. In addition, the study will identify and evaluate the prevalence of late adverse effects and analyze their association with diagnosis and specific oncological treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with colorectal cancer (colon or rectal cancer)
- •Age 25 to 65 years
- •First oncological treatment performed at the Institute of Oncology Ljubljana
- •Working-capable patients
- •Ability to complete questionnaires
- •Ability to provide written informed consent
排除标准
- •Age < 25 years or > 65 years
- •Patients unable to complete questionnaires
- •Patients unable to participate in follow-up assessments
- •Patients who do not provide written informed consent
研究组 & 干预措施
Quality of Life Assessment Group
Participants with colorectal cancer after oncological treatment will complete quality of life assessments at 6, 12, and 24 months to identify late adverse effects and evaluate psycho-physical-social well-being.
干预措施: Quality of Life Assessment (Other)
结局指标
主要结局
Quality of Life Score (EORTC QLQ-C30 Global Health Status/QoL Scale)
时间窗: 6, 12, and 24 months after oncological treatment
Quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), specifically the Global Health Status/Quality of Life scale (items 29 and 30). Scores will be linearly transformed to a 0 to 100 scale. Higher scores indicate better quality of life.
次要结局
- Colorectal Cancer-Specific Quality of Life (EORTC QLQ-CR29)(6, 12, and 24 months after oncological treatment)